State Street’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$218M Buy
5,663,543
+723,243
+15% +$26.7M 0.01% 894
2025
Q4
$175M Buy
4,940,300
+164,881
+3% +$4.64M 0.01% 1016
2025
Q3
$68.6M Buy
4,775,419
+1,403,507
+42% +$16.6M ﹤0.01% 1567
2025
Q2
$24.2M Sell
3,371,912
-744,884
-18% -$4.13M ﹤0.01% 2083
2025
Q1
$24.7M Buy
4,116,796
+198,666
+5% +$1.56M ﹤0.01% 2008
2024
Q4
$30.6M Buy
3,918,130
+686,668
+21% +$6.84M ﹤0.01% 1973
2024
Q3
$34.9M Sell
3,231,462
-605,500
-16% -$5.9M ﹤0.01% 1881
2024
Q2
$32.3M Sell
3,836,962
-3,789,907
-50% -$28.7M ﹤0.01% 1888
2024
Q1
$51.3M Buy
7,626,869
+3,476,254
+84% +$21.5M ﹤0.01% 1716
2023
Q4
$24.4M Buy
4,150,615
+1,182,980
+40% +$9.07M ﹤0.01% 2100
2023
Q3
$28.9M Sell
2,967,635
-160,468
-5% -$1.9M ﹤0.01% 1938
2023
Q2
$37M Sell
3,128,103
-299,611
-9% -$3.44M ﹤0.01% 1853
2023
Q1
$37M Sell
3,427,714
-833,667
-20% -$10.7M ﹤0.01% 1841
2022
Q4
$49.3M Buy
4,261,381
+852,779
+25% +$10.6M ﹤0.01% 1651
2022
Q3
$50.9M Buy
3,408,602
+2,714,447
+391% +$37.2M ﹤0.01% 1588
2022
Q2
$6.26M Buy
694,155
+68,523
+11% +$468K ﹤0.01% 2982
2022
Q1
$4.69M Buy
625,632
+27,624
+5% +$192K ﹤0.01% 3212
2021
Q4
$5.13M Buy
598,008
+14,993
+3% +$130K ﹤0.01% 3231
2021
Q3
$4.9M Buy
583,015
+76,158
+15% +$584K ﹤0.01% 3249
2021
Q2
$4.11M Buy
506,857
+486,657
+2,409% +$4.11M ﹤0.01% 3339
2021
Q1
$177K Hold
20,200
﹤0.01% 3858
2020
Q4
$227K Buy
+20,200
New +$222K ﹤0.01% 3739
2019
Q2
Sell
-53,865
Closed -$946K 3825
2019
Q1
$946K Buy
53,865
+10,826
+25% +$185K ﹤0.01% 3348
2018
Q4
$757K Buy
43,039
+26,079
+154% +$772K ﹤0.01% 3378
2018
Q3
$699K Buy
16,960
+11,185
+194% +$630K ﹤0.01% 3444
2018
Q2
$331K Buy
+5,775
New +$278K ﹤0.01% 3516

Other funds holding COGT